Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D p hydroxyphenylglycine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 2-step synthesis for D-p-hydroxyphenylglycine methyl ester hydrochloride. Reduces cost and waste for amoxicillin production. High purity and yield.
Novel recombinant E. coli route for D-HPG production offers cost reduction in API intermediate manufacturing and enhanced supply chain reliability for global pharmaceutical partners.
Patent CN102757356B details a cost-effective splitting process for D-HPG. Enhances supply chain reliability and reduces waste in API intermediate manufacturing significantly.
Patent CN102757367A details a cost-effective splitting process for DL-benzene ethyl sulfonic acid using L-HPG, offering high purity and supply chain stability for pharmaceutical intermediates.
Patent CN113896645A reveals a one-pot synthesis method for D-p-HPG. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113896645B enables clean synthesis of D-p-HPG. Reduces waste and improves yield for reliable pharmaceutical intermediates supply chains.
Patent CN110330460B details a high-yield solid acid catalyzed route for p-hydroxyphenylhydantoin, offering cost reduction in API manufacturing and enhanced supply chain reliability.